https://www.selleckchem.com/products/gdc-0077.html
Omega-3 fatty acids reduced SLE activity [SMD -0.33 (95CI -0.57, -0.09), low certainty evidence, moderate effect size]. Transforming the SMD to the SLE Disease Activity Index (SLEDAI) scale, omega-3 fatty acids reduced disease activity by 0.9 (95CI -1.6, -0.3, I = 0%) SLEDAI points compared to placebo. This meta-analysis suggests that omega-3 fatty acids could provide therapeutic benefit in addition to immunosuppressive regimens used for SLE. This meta-analysis suggests that omega-3 fatty acids could provide therapeutic benefit in add
Like
Comment
Share
